Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
+$2.09B |
| 2 |
Mastercard
MA
|
+$2.06B |
| 3 |
UnitedHealth
UNH
|
+$1.3B |
| 4 |
Coca-Cola
KO
|
+$1.17B |
| 5 |
Marsh & McLennan
MMC
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.55B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
JPMorgan Chase
JPM
|
+$1.34B |
| 4 |
General Dynamics
GD
|
+$1.25B |
| 5 |
Wells Fargo
WFC
|
+$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Heron Therapeutics
HRTX
$199M
| $1.07M | ﹤0.01% |
487,242
-880
| -0.2% | -$1.94K |
|
1602
Organogenesis Holdings
ORGO
$605M
| $1.06M | ﹤0.01% |
245,548
-8,734
| -3% | -$37.7K |
|
1603
Flowers Foods
FLO
$3.15B
| $1.05M | ﹤0.01% |
55,401
+3,750
| +7% | +$71.3K |
|
1604
Zevra Therapeutics
ZVRA
$468M
| $1.05M | ﹤0.01% |
+140,418
| New | +$1.05M |
|
1605
Capricor Therapeutics
CAPR
$290M
| $1.05M | ﹤0.01% |
110,731
+69,772
| +170% | +$662K |
|
1606
Citigroup
C
$176B
| $1.04M | ﹤0.01% |
14,718
-29,764
| -67% | -$2.11M |
|
1607
APA Corp
APA
$7.96B
| $1.04M | ﹤0.01% |
49,636
-57,578
| -54% | -$1.21M |
|
1608
Descartes Systems
DSGX
$9.23B
| $1.04M | ﹤0.01% |
10,357
+2,400
| +30% | +$242K |
|
1609
Equity Lifestyle Properties
ELS
$11.9B
| $1.04M | ﹤0.01% |
15,604
+3,550
| +29% | +$237K |
|
1610
Elastic
ESTC
$9.81B
| $1.04M | ﹤0.01% |
11,632
+6,218
| +115% | +$554K |
|
1611
Immunome
IMNM
$818M
| $1.03M | ﹤0.01% |
153,011
+7,447
| +5% | +$50.1K |
|
1612
Amylyx Pharmaceuticals
AMLX
$931M
| $1.03M | ﹤0.01% |
290,682
+80,974
| +39% | +$287K |
|
|
JNPR
1613
DELISTED
Juniper Networks
JNPR
| $1.02M | ﹤0.01% |
28,284
+4,612
| +19% | +$167K |
|
1614
Park Aerospace
PKE
$379M
| $1.02M | ﹤0.01% |
+75,900
| New | +$1.02M |
|
1615
iShares Global Energy ETF
IXC
$1.8B
| $1.01M | ﹤0.01% |
+24,038
| New | +$1.01M |
|
1616
CorMedix
CRMD
$952M
| $1.01M | ﹤0.01% |
163,949
-14,837
| -8% | -$91.4K |
|
1617
SIGA Technologies
SIGA
$620M
| $999K | ﹤0.01% |
182,328
+62,103
| +52% | +$340K |
|
1618
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.7B
| $998K | ﹤0.01% |
5,055
-1,096
| -18% | -$216K |
|
1619
Oric Pharmaceuticals
ORIC
$1.02B
| $994K | ﹤0.01% |
178,217
-8,213
| -4% | -$45.8K |
|
1620
Arcturus Therapeutics
ARCT
$484M
| $984K | ﹤0.01% |
92,874
-4,162
| -4% | -$44.1K |
|
1621
Verastem
VSTM
$630M
| $977K | ﹤0.01% |
+162,064
| New | +$977K |
|
1622
Tyra Biosciences
TYRA
$646M
| $968K | ﹤0.01% |
104,087
+9,228
| +10% | +$85.8K |
|
1623
Virtu Financial
VIRT
$3.26B
| $964K | ﹤0.01% |
25,288
-1,463
| -5% | -$55.8K |
|
1624
Vodafone
VOD
$28.4B
| $962K | ﹤0.01% |
102,661
-11,639
| -10% | -$109K |
|
1625
Cloudflare
NET
$75.9B
| $945K | ﹤0.01% |
8,382
+2,452
| +41% | +$276K |
|